Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.  [electronic resource] 

 -  Circulation  Sep 2016 
 - e156-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIR.0000000000000405  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Advisory Committees--standards<br/>American Heart Association<br/>Aspirin--administration & dosage<br/>Cardiology--methods<br/>Coronary Artery Disease--diagnosis<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Drug-Eluting Stents--adverse effects<br/>Hemorrhage--chemically induced<br/>Humans<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Practice Guidelines as Topic--standards<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Randomized Controlled Trials as Topic--methods<br/>Research Report--standards<br/>Thrombosis--etiology<br/>Time Factors<br/>United States--epidemiology